{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:52:27Z","timestamp":1793987547852,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41417-025-00988-4","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:13:16Z","timestamp":1763367196000},"page":"116-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Meta single-cell atlas and xQTL post-GWAS analysis revealed the pathogenic features of thyroid cancer for target therapy: A multi-omics study"],"prefix":"10.1038","volume":"33","author":[{"given":"Cong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6350-698X","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-4868","authenticated-orcid":false,"given":"Biao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"988_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"988_CR2","doi-asserted-by":"publisher","first-page":"dgaa223","DOI":"10.1210\/clinem\/dgaa223","volume":"105","author":"R Vigneri","year":"2020","unstructured":"Vigneri R, Malandrino P, Russo M. Is Thyroid Cancer Increasing in Incidence and Aggressiveness?. J Clin Endocrinol Metab. 2020;105:dgaa223.","journal-title":"J Clin Endocrinol Metab"},{"key":"988_CR3","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401:1531\u201344.","journal-title":"Lancet"},{"key":"988_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103957","volume":"184","author":"Y Ma","year":"2023","unstructured":"Ma Y, Zhang Q, Zhang K, liang Y, Ren F, Zhang J, et al. NTRK fusions in thyroid cancer: Pathology and clinical aspects. Crit Rev Oncol\/Hematol. 2023;184:103957.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"988_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: A Review. JAMA. 2024;331:425\u201335.","journal-title":"JAMA"},{"key":"988_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13:184\u201399.","journal-title":"Nat Rev Cancer"},{"key":"988_CR7","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1210\/jc.2005-0987","volume":"90","author":"M Xing","year":"2005","unstructured":"Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, et al. BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer. J Clin Endocrinol Metab. 2005;90:6373\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"988_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41574-020-00448-z","volume":"17","author":"M Schlumberger","year":"2021","unstructured":"Schlumberger M, Leboulleux S. Current practice in patients with differentiated thyroid cancer. Nat Rev Endocrinol. 2021;17:176\u201388.","journal-title":"Nat Rev Endocrinol"},{"key":"988_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45366-0","volume":"15","author":"SE Lee","year":"2024","unstructured":"Lee SE, Park S, Yi S, Choi NR, Lim MA, Chang JW, et al. Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses. Nat Commun. 2024;15:1163.","journal-title":"Nat Commun"},{"key":"988_CR10","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1089\/thy.2023.0272","volume":"33","author":"A Papadopoulou","year":"2023","unstructured":"Papadopoulou A, \u00c5svold BO, Burgess S, Ku\u015b A, Medici M, Sterenborg R, et al. Height, autoimmune thyroid disease and thyroid cancer: a Mendelian randomisation study. Thyroid. 2023;33:1476\u201382.","journal-title":"Thyroid"},{"key":"988_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217259","volume":"604","author":"C Zhang","year":"2024","unstructured":"Zhang C, Gou X, Lai G, Li K, Zhu X, Liu N, et al. Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: Insights into pathogenic origins and treatment-responsive cellular subgroups. Cancer Lett. 2024;604:217259.","journal-title":"Cancer Lett"},{"key":"988_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s13167-024-00374-4","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yang J, Chen S, Sun L, Li K, Lai G, et al. Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling. EPMA J. 2024;15:525\u201344.","journal-title":"EPMA J"},{"key":"988_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01356-x","volume":"16","author":"S Si","year":"2024","unstructured":"Si S, Liu H, Xu L, Zhan S. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Genome Med. 2024;16:84.","journal-title":"Genome Med"},{"key":"988_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01229-9","volume":"15","author":"J Sun","year":"2023","unstructured":"Sun J, Zhao J, Jiang F, Wang L, Xiao Q, Han F, et al. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome. Genome Med. 2023;15:75.","journal-title":"Genome Med"},{"key":"988_CR15","doi-asserted-by":"crossref","unstructured":"Guo Y, Xu T, Luo J, Jiang Z, Chen W, Chen H, et al. SMR-Portal: an online platform for integrative analysis of GWAS and xQTL data to identify complex trait genes. Nat Methods 2025;22:220\u2013222.","DOI":"10.1038\/s41592-024-02561-7"},{"key":"988_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481\u20137.","journal-title":"Nat Genet"},{"key":"988_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27850-z","volume":"13","author":"A Gudjonsson","year":"2022","unstructured":"Gudjonsson A, Gudmundsdottir V, Axelsson GT, Gudmundsson EF, Jonsson BG, Launer LJ, et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat Commun. 2022;13:480.","journal-title":"Nat Commun"},{"key":"988_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10462-024-10884-2","volume":"57","author":"M Salmi","year":"2024","unstructured":"Salmi M, Atif D, Oliva D, Abraham A, Ventura S. Handling imbalanced medical datasets: review of a decade of research. Artif Intell Rev. 2024;57:273.","journal-title":"Artif Intell Rev"},{"key":"988_CR19","doi-asserted-by":"publisher","unstructured":"Huo Z, Qian X, Huang S, Wang Z, Mortazavi BJ. Density-Aware personalized training for risk prediction in imbalanced medical data. 2022. https:\/\/doi.org\/10.48550\/arXiv.2207.11382.","DOI":"10.48550\/arXiv.2207.11382"},{"key":"988_CR20","doi-asserted-by":"publisher","first-page":"e0269713","DOI":"10.1371\/journal.pone.0269713","volume":"17","author":"J Albuquerque","year":"2022","unstructured":"Albuquerque J, Medeiros AM, Alves AC, Bourbon M, Antunes M. Comparative study on the performance of different classification algorithms, combined with pre- and post-processing techniques to handle imbalanced data, in the diagnosis of adult patients with familial hypercholesterolemia. PLoS ONE. 2022;17:e0269713.","journal-title":"PLoS ONE"},{"key":"988_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12022-023-09756-2","volume":"34","author":"ED Rossi","year":"2023","unstructured":"Rossi ED, Baloch Z. The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology. Endocr Pathol. 2023;34:23\u201333.","journal-title":"Endocr Pathol"},{"key":"988_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33:27\u201363.","journal-title":"Endocr Pathol"},{"key":"988_CR23","unstructured":"65eb935732f442bc9e98e463fa6cfead.pdf. https:\/\/chinanm.cma.org.cn\/attach\/0\/65eb935732f442bc9e98e463fa6cfead.pdf (accessed 21 Jan2025)."},{"key":"988_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12022-023-09749-1","volume":"34","author":"CM Sande","year":"2023","unstructured":"Sande CM, Tondi Resta I, Livolsi VA. The Thyroid Pathologist Meets Therapeutic Pharmacology. Endocr Pathol. 2023;34:48\u201356.","journal-title":"Endocr Pathol"},{"key":"988_CR25","first-page":"775","volume":"55","author":"S Zhang","year":"2019","unstructured":"Zhang S, Mo Q, Wang X. Oncological role of HMGA2 (Review). Int J Oncol. 2019;55:775\u201388.","journal-title":"Int J Oncol"},{"key":"988_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1677\/JME-09-0178","volume":"44","author":"M Fedele","year":"2010","unstructured":"Fedele M, Fusco A. Role of the high mobility group A proteins in the regulation of pituitary cell cycle. J Mol Endocrinol. 2010;44:309\u201318.","journal-title":"J Mol Endocrinol"},{"key":"988_CR27","doi-asserted-by":"publisher","first-page":"10764","DOI":"10.3390\/ijms241310764","volume":"24","author":"C Van Branteghem","year":"2023","unstructured":"Van Branteghem C, Augenlicht A, Demetter P, Craciun L, Maenhaut C. Unraveling the Roles of miR-204-5p and HMGA2 in Papillary Thyroid Cancer Tumorigenesis. Int J Mol Sci. 2023;24:10764.","journal-title":"Int J Mol Sci"},{"key":"988_CR28","first-page":"53","volume":"229","author":"D Califano","year":"2014","unstructured":"Califano D, Pignata S, Losito NS, Ottaiano A, Greggi S, De Simone V, et al. High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer. J Cell Physiol. 2014;229:53\u20139.","journal-title":"J Cell Physiol"},{"key":"988_CR29","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301070RR","volume":"37","author":"Y Cao","year":"2023","unstructured":"Cao Y, Li J, Du Y, Sun Y, Liu L, Fang H, et al. LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1. FASEB J. 2023;37:e23288.","journal-title":"FASEB J"},{"key":"988_CR30","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3892\/ijmm.2016.2705","volume":"38","author":"Y-C Wang","year":"2016","unstructured":"Wang Y-C, Liu J-S, Tang H-K, Nie J, Zhu J-X, Wen L-L, et al. miR\u2011221 targets HMGA2 to inhibit bleomycin\u2011induced pulmonary fibrosis by regulating TGF\u2011\u03b21\/Smad3-induced EMT. Int J Mol Med. 2016;38:1208\u201316.","journal-title":"Int J Mol Med"},{"key":"988_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbrc.2015.05.068","volume":"463","author":"Y-Y Xia","year":"2015","unstructured":"Xia Y-Y, Yin L, Jiang N, Guo W-J, Tian H, Jiang X-S, et al. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells. Biochem Biophys Res Commun. 2015;463:357\u201363.","journal-title":"Biochem Biophys Res Commun"},{"key":"988_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/0008-5472.CAN-23-1490","volume":"84","author":"D Wang","year":"2024","unstructured":"Wang D, Nakayama M, Hong CP, Oshima H, Oshima M. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGF\u03b2 Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors. Cancer Res. 2024;84:56\u201368.","journal-title":"Cancer Res"},{"key":"988_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12020-024-03933-x","volume":"86","author":"H Sun","year":"2024","unstructured":"Sun H, Li L, Yan J, Huang T. Prioritization of drug targets for thyroid cancer: a multi-omics Mendelian randomization study. Endocrine. 2024;86:732\u201343.","journal-title":"Endocrine"},{"key":"988_CR34","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1158\/1078-0432.CCR-17-1183","volume":"23","author":"T Ibrahimpasic","year":"2017","unstructured":"Ibrahimpasic T, Xu B, Landa I, Dogan S, Middha S, Seshan V, et al. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clin Cancer Res. 2017;23:5970\u201380.","journal-title":"Clin Cancer Res"},{"key":"988_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14517","volume":"8","author":"J Gudmundsson","year":"2017","unstructured":"Gudmundsson J, Thorleifsson G, Sigurdsson JK, Stefansdottir L, Jonasson JG, Gudjonsson SA, et al. A genome-wide association study yields five novel thyroid cancer risk loci. Nat Commun. 2017;8:14517.","journal-title":"Nat Commun"},{"key":"988_CR36","first-page":"5179","volume":"37","author":"B Wojtczak","year":"2017","unstructured":"Wojtczak B, Pula B, Gomulkiewicz A, Olbromski M, Podhorska-Okolow M, Domoslawski P, et al. Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions. Anticancer Res. 2017;37:5179\u201385.","journal-title":"Anticancer Res"},{"key":"988_CR37","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.3390\/ijms21155580","volume":"21","author":"S Anand","year":"2020","unstructured":"Anand S, Khan MA, Khushman M, Dasgupta S, Singh S, Singh AP. Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer. Int J Mol Sci. 2020;21:5580.","journal-title":"Int J Mol Sci"},{"key":"988_CR38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/ijc.31156","volume":"142","author":"J Brandt","year":"2018","unstructured":"Brandt J, Borgquist S, Almgren P, F\u00f6rsti A, Huss L, Melander O, et al. Thyroid-associated genetic polymorphisms in relation to breast cancer risk in the Malm\u00f6 Diet and Cancer Study. Int J Cancer. 2018;142:1309\u201321.","journal-title":"Int J Cancer"},{"key":"988_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1132242","volume":"14","author":"S Ren","year":"2023","unstructured":"Ren S, Cao W, Ma J, Li H, Xia Y, Zhao J. Correlation evaluation between cancer microenvironment related genes and prognosis based on intelligent medical internet of things. Front Genet. 2023;14:1132242.","journal-title":"Front Genet"},{"key":"988_CR40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1198\/016214503000125","volume":"98","author":"P B\u00fchlmann","year":"2003","unstructured":"B\u00fchlmann P, Yu B. Boosting With the L2 Loss: Regression and Classification. J Am Stat Assoc. 2003;98:324\u201339.","journal-title":"J Am Stat Assoc"},{"key":"988_CR41","doi-asserted-by":"publisher","unstructured":"B\u00fchlmann P. Boosting for high-dimensional linear models. Ann Statist 2006;34. https:\/\/doi.org\/10.1214\/009053606000000092.","DOI":"10.1214\/009053606000000092"},{"key":"988_CR42","doi-asserted-by":"publisher","unstructured":"B\u00fchlmann P, Hothorn T. Boosting Algorithms: Regularization, Prediction and Model Fitting. Statist Sci 2007;22. https:\/\/doi.org\/10.1214\/07-STS242.","DOI":"10.1214\/07-STS242"},{"key":"988_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00180-012-0382-5","volume":"29","author":"B Hofner","year":"2014","unstructured":"Hofner B, Mayr A, Robinzonov N, Schmid M. Model-based boosting in R: a hands-on tutorial using the R package mboost. Comput Stat. 2014;29:3\u201335.","journal-title":"Comput Stat"},{"key":"988_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.12677\/AIRR.2024.131016","volume":"13","author":"J Xiang","year":"2024","unstructured":"Xiang J. A Review of Machine Learning Classification Based on Random Forest Algorithm. AIRR. 2024;13:143\u201352.","journal-title":"AIRR"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00988-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T23:02:39Z","timestamp":1768172559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00988-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00988-4","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve any experiments on human participants, human tissues, or animals conducted by the authors. All data used in this research were obtained from publicly available and fully anonymized databases (e.g., GEO and TCGA). According to the policies of our institutional ethics committee, ethical review and informed consent were not required for studies based solely on publicly available data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}